Status:
UNKNOWN
A Novel Non-Pharmacological Treatment of Diabetic Neuropathy
Lead Sponsor:
Auburn University
Conditions:
Diabetic Peripheral Neuropathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the proposed work is to develop non-pharmacological interventions for diabetic peripheral neuropathy (DPN), to improve quality of life of individuals with diabetes, and reduce the pre...
Detailed Description
To address a gap in DPN treatments, we propose a pragmatic approach towards the development of mechanistically justified therapies to treat DPN. Specifically, we seek to explore undertested non-pharma...
Eligibility Criteria
Inclusion
- diagnosis of type 2 diabetes for at least 5 years
- lab histories that verify participant's control or lack of blood sugars dating back for a period of 1-5 years
Exclusion
- other diseases or impairments that could affect results (vascular disease verified from medical history
- ankle-brachial index (ABI) of 0.9 or less
Key Trial Info
Start Date :
March 22 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT05414968
Start Date
March 22 2023
End Date
June 1 2025
Last Update
August 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Auburn University
Auburn, Alabama, United States, 36849